In April, the American Psychiatric Association (APA) released a comprehensive treatment guideline for treating adults who have been diagnosed with schizophrenia. Titled "The Practice Guideline for ...

Schizophrenia is a serious mental disorder that affects around 1% of the world’s population. Researchers of the University of ...

The proportion of new schizophrenia cases linked to cannabis use has nearly tripled in almost two decades, increasing ...

The acute phase of schizophrenia is the florid psychotic phase, during which the patient exhibits acute symptoms--for example, severe delusions and/or hallucinations (positive symptoms ...

The proportion of new cases of schizophrenia associated with a cannabis use disorder has risen from 4% pre-legalization to 10 ...

Jan. 28, 2025 — Schizophrenia is a serious mental disorder that affects around 1% of the world's population. Researchers have identified a deficit in contrast perception in people with ...

People with schizophrenia have at least two of these symptoms for at least six months. One of them must be hallucinations, delusions, or disorganized speech. For example, hearing a voice that ...

The proportion of new cases of schizophrenia associated with a cannabis use disorder has risen from 4% pre-legalization to 10 ...

People with schizophrenia have an altered ability to visually perceive contrast. ScienceDaily . Retrieved February 1, 2025 from www.sciencedaily.com / releases / 2025 / 01 / 250128123926.htm ...

Usually described as a splitting or multiple personality disorder, the concept of schizophrenia is not entirely but rather a ...

The Food and Drug Administration approved the first new drug in over 30 years to treat schizophrenia in adults. The new drug Cobenfy, formerly known as KarXT, is manufactured by Bristol Myers ...